Medicine

DEA takes some CBD off Schedule 1 – with FDA approval

DEA takes some CBD off Schedule 1 – with FDA approval

“The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.” - Hemp Industry Daily

Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Not a member? Sign up. Log Out